Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01341938 · ClinicalTrials.gov registry record · NA
Nicotine Lozenges and Assisted Self-help for Smokeless Tobacco Cessation
A NA study, sponsored by Oregon Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 1,067
- Enrollment target
NCT01341938 is a NA study that has completed, run by Oregon Research Institute. The registered enrollment target is 1,067 participants.
The verdict
NCT01341938, a NA study, has completed, sponsored by Oregon Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,067 participants
- Enrollment target
Study Summary
This research study will determine if using a combination of 4-mg nicotine lozenges, self-help materials, and/or telephone tobacco cessation counseling will help smokeless tobacco users stop using tobacco. The study will consist of three interventions: 1. The Lozenge Assisted Self-help intervention - lozenge nicotine replacement therapy, phone counseling, and self help materials 2. Assisted Self-Help intervention - self-help materials and phone counseling without lozenges 3. Lozenge Self Help intervention - self help materials and lozenge nicotine replacement therapy. Hypothesis: The Lozenge Assisted Self-help intervention will significantly increase both the prolonged and point prevalence for all tobacco and smokeless tobacco (ST) abstinence rates at 6 months among ST users who are interested in achieving tobacco abstinence, compared to those in the Assisted Self-Help intervention and the Lozenge Self Help intervention.
Interventions
- DRUG Commit® nicotine lozenges (4 mg) & self-help materials
- BEHAVIORAL Commit® nicotine lozenges (4 mg) & phone counseling & self-help materials
- BEHAVIORAL Phone counseling & self-help materials
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,067 participants |
| Start Date | 2011-07 |
| Est. Completion | 2012-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01341938
The ClinicalTrials.gov registry entry for NCT01341938 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,067 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Research Institute, which has 62 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Commit® nicotine lozenges (4 mg) & self-help materials is the first listed.
NCT01341938 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01341938 about?
NCT01341938 is a clinical study titled "Nicotine Lozenges and Assisted Self-help for Smokeless Tobacco Cessation". This research study will determine if using a combination of 4-mg nicotine lozenges, self-help materials, and/or telephone tobacco cessation counseling will help smokeless tobacco users stop using tobacco. The study will consist of three interventions: 1. The Lozenge Assisted Self-help intervention...
What is the current status of trial NCT01341938?
This trial is currently completed. It is a NA study. The enrollment target is 1,067 participants. The study started on 2011-07. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01341938?
The interventions under investigation include: Commit® nicotine lozenges (4 mg) & self-help materials (DRUG), Commit® nicotine lozenges (4 mg) & phone counseling & self-help materials (BEHAVIORAL), Phone counseling & self-help materials (BEHAVIORAL).
Who is sponsoring clinical trial NCT01341938?
This trial is sponsored by Oregon Research Institute, which has 62 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.